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The National Health Insurance Service (NHIS) of Korea provides health insurance for 
over 90% of the population. The prevalence of smoking among Korean men is one of 
the highest in developed countries, and cancer incidence and mortality rates are the 
highest among all Asian countries (1). The NHIS has taken legal action against both 
Korean and international tobacco companies, and recently suffered a blow at the 
Supreme Court (2). This has attracted comment in Korean epidemiology journals 
(3,4). The familiarity of the issues from the history of epidemiology in Europe and 
America make the case disturbing and deserving of international attention. In 
particular, three aspects of the judgment (all identified as problematic in (4)) deserve 
emphasis. 
First, tobacco companies successfully argued that, beyond statutory warning 
labels, they had no duty to warn smokers of the dangers of smoking. Legislation 
obliges manufacturers to place specific warnings on packets, but the question 
concerned whether the statutory labels satisfied a duty to warn of the dangers of 
smoking. The court found no further duty, on the basis that the dangers of smoking 
are already widely known. 
Even if the dangers of smoking are better known than they used to be, it is 
hard to accept that education is sufficient in this regard, especially given the relation 
between age of starting smoking, difficulty of stopping, duration of smoking habit, 
and risk of smoking-related diseases. Moreover, even if the present notoriety of 
smoking is deemed sufficient, this notoriety is largely because of the efforts of 
epidemiologists and others involved in public health. The Korean Supreme Court’s 
decision implies that the efforts of epidemiologists and others involved in public 
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health to raise awareness of the dangers of smoking have relieved tobacco companies 
operating in Korea of the cost of doing so, thus effectively improving the profitability 
of selling cigarettes in Korea. The idea that an epidemiologist who has worked hard to 
raise awareness of the dangers of smoking has thereby helped relieve a tobacco 
company of a duty to warn is troubling, from the perspective of the profession. 
The second troubling feature of the judgment concerns a distinction between 
specific and non-specific diseases. The Korean Supreme Court has been convinced 
that diseases come in two kinds, specific and non-specific, with a specific disease 
being one with a characteristic cause, and a non-specific disease arising from more 
than one constellation of causes (for more detail on this distinction see (4)). The idea 
is that, because smoking is non-specific, a plaintiff needs to show that it was smoking 
and not something else that caused the lung-cancer. 
The distinction between specific and non-specific diseases does not bear the 
weight that this judgment places upon it. All diseases arise from a constellation of 
factors (5). Some diseases have necessary causes, such that, without the cause, it 
would be a different disease (6,7): for example, diarrhea without vibrio cholerae is not 
cholera. Such diseases would presumably count as “specific” in the Court’s 
categorization. However, this feature does not have the over-riding significance for 
causal inference that the Court seems to attribute. If one sees a case of diarrhea with 
vibrio cholerae present, then indeed one can make an inference that the vibrio 
cholerae is causing the diarrhea; but it remains possible that another cause is present. 
So even in the case of a so-called specific disease, one needs to show that the cause in 
question and not something else is causing the disease. This might be easier to do for 
a specific disease, but for some non-specific disease such as smoking, where the 
relative risks are very high, it might also be relatively easy to make a compelling case, 
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based on the statistical rarity of lung cancer among non-smokers. The crucial point is 
that the underlying inference is non-deductive in character in the imaginary cholera 
case as in the smoking case. Thus the distinction simply does not have the 
significance that the Court places upon it. 
The third troubling feature of the case is an apparent resistance to 
acknowledging any link between epidemiological evidence and the individual case. 
This resistance is not unique to Korean law. There is substantial jurisprudential 
literature on the difficulties of using statistical evidence to prove claims about 
individuals (8–12), and this is because this use of statistical evidence raises 
foundational issues in both jurisprudence and epistemology. Nonetheless it is 
troubling that the situation around the relevance of epidemiological evidence to proof 
of specific causation remains so poorly understood, given that the use of statistical 
evidence in other areas, such as forensics, is now commonplace and even a necessity. 
It is possible to clarify at least the epistemic significance of statistical evidence in the 
epidemiological case, in the following way. 
Suppose, hypothetically, that the relative risk of lung cancer among a certain 
subgroub of male smokers (say, 20 or more per day for 30 or more years) in a certain 
population is 20, compared to never-smokers. Then the excess fraction of lung cancer 
among these smokers is 1 െ 1 20ൗ ൌ 19 20ൗ  or 0.95. Let us assume that, after 
carefully considering a wide range of evidence, we make a causal inference, and 
conclude that this excess fraction is caused by the differences in smoking habits 
between the two groups. 
Now suppose that we take a randomly selected smoker from our group. 
Assuming that no other evidence is available that might bear on this individual’s 
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probability of developing lung cancer without smoking, what is the probability that 
this randomly selected smoker would have developed lung cancer had he been in the 
control group? This is the probability of picking a smoker who would not have been 
part of the excess fraction of 95%; thus it is 5%. 
This does not immediately tell us how probably smoking is causal in a given 
randomly selected case. Etiologic fraction may exceed excess fraction (13): smoking 
may be a contributory factor in the development of lung cancer even among those 
who would have developed it anyway. Because causes can contribute to effects that 
would have happened anyway, while epidemiological evidence tracks only net 
differences between groups, we cannot use epidemiological evidence to give us an 
equation for the probability of causation. 
However, assuming that the net difference between the two groups is caused 
by the exposure, we know that the exposure is causal in at least that many cases—
perhaps more (because etiologic fraction may exceed excess fraction), but not less (or 
the causal inference would be confounded, contra our assumption). In that case, we 
can devise an inequality (7,12):  
ܲܥ ൒ 1 െ 1 ܴܴൗ  
It would be a mistake to treat this as determinative of causation in an 
individual case. Other kinds of evidence, such as family history, or whether the 
individual worked in an asbestos factory, may render a population-based estimate less 
relevant. Moreover, because this is an inequality, this formula cannot be used to 
establish a threshold level for the admissibility of epidemiological evidence in relation 
to causation. 
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These caveats are important and mean that caution must be exercised in 
applying population-level epidemiological evidence to individual cases. Nonetheless, 
it is a myth that epidemiological evidence is totally silent on causation in the 
individual case. Epidemiological evidence does yield probabilistic conclusions about 
individuals, if certain assumptions are satisfied (12), and arriving at probabilistic 
conclusions about individuals when certain assumptions are satisfied is part of what 
law courts do. It is unfortunate that unclear thinking about the relation between 
epidemiological evidence and specific causation persists in legal contexts. 
In summary, is troubling that tobacco companies are successfully using 
strategies in Korea which have been tried and found wanting in other jurisdictions. 
The issue of the duty to warn appears to be an old trick which probably would not 
work in many other jurisdictions. The other two issues, of specific/non-specific 
diseases and of epidemiological evidence in proof of individual causation, amount to 
a different old trick: that of linking a defense to foundational, even philosophical, 
issues, which therefore cannot be decisively resolved. One name for this trick is 
obfuscation, and a defense that pulls this trick off is difficult to dislodge. 
However, regarding both these latter issues (specific/non-specific diseases, 
and proof of individual causation using epidemiological evidence), we believe that it 
is possible to achieve a useful degree of clarification without pretending to solve the 
foundational issues, and thus to achieve a more satisfactorily reasoned position. A 
reasoned engagement leads us to conclude that the distinction between specific and 
non-specific diseases cannot bear the weight placed on it in the Supreme Court’s 
judgment, and also that epidemiological evidence can be used in at least some 
circumstances to show that individual causation is more probable than not. 
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These modest conclusions are not complete solutions to the respective 
underlying theoretical problems, but they are more reasonable and more useful than 
the stances that the Court was persuaded to take in its judgment. Philosophical 
argument can obfuscate, but it can also clarify. Perhaps the strategy of limited and 
reasoned engagement is not strictly a new answer to old tricks. However, there is a 
newly emergent appreciation of the philosophical foundations of epidemiology (7), 
and the analyses of specific/non-specific diseases and probability of causation here 
arises from that work. 
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